Robert Wessman
CHAIRMAN AND CEO
finance
Kosmo Science
Portugal
Biography
As founder and CEO, Wessman has led Alvogen from being a small US based contract manufacturing business to becoming a top 15 global generics player operating in 35 countries in only six years. Alvogen has received multiple industry recognitions including CPhI Company of the Year Awards and multiple service awards. Development of a balanced yet specialized portfolio consisting of 500 marketed products, as well as a deep pipeline of high-value products in development, is at the core of Wessman’s strategy enabling Alvogen to proactively respond to market needs and fuel sustainable and profitable growth.
Research Interest
Gastroenterology